Based on our results showing that 10–20% WT hematopoietic chimerism is sufficient to reestablish normal immune regulation,6 we investigated the feasibility of HSC gene therapy for perforin deficiency. This evidence concerns the gene PRF1 and hyperinsulinemic hypoglycemia, familial, 4.